Anthony Hessel, PhD
@hesselanthony.bsky.social
370 followers
170 following
230 posts
Muscle physiologist at Uni of Muenster. Founder, Accelerated Muscle Biotechnologies. Dog foster / diva boston terrier parent. My wife tolerates me well. He/him.🥼🧪🔬💪♥️ #MyoBlue #NoKing
Posts
Media
Videos
Starter Packs
Reposted by Anthony Hessel, PhD
Reposted by Anthony Hessel, PhD
Reposted by Anthony Hessel, PhD
Reposted by Anthony Hessel, PhD
Ken Campbell
@cardiaccampbell.bsky.social
· Aug 20
Danicamtiv reduces myosin’s working stroke but activates the thin filament by accelerating actomyosin attachment | PNAS
Heart failure is a leading cause of death worldwide, and even with current treatments,
the 5-y transplant-free survival rate is only ~50 to 70%. As...
www.pnas.org
Reposted by Anthony Hessel, PhD
Reposted by Anthony Hessel, PhD
Reposted by Anthony Hessel, PhD
Reposted by Anthony Hessel, PhD
Joseph Gordon
@josephwgordon.bsky.social
· Jul 15
Muscle mass loss during GLP1 receptor agonist therapy prevented with GDF8 and activin A blockade - Nature Reviews Endocrinology
Nature Reviews Endocrinology - Muscle mass loss during GLP1 receptor agonist therapy prevented with GDF8 and activin A blockade
www.nature.com
Reposted by Anthony Hessel, PhD
Reposted by Anthony Hessel, PhD
Reposted by Anthony Hessel, PhD
Reposted by Anthony Hessel, PhD